OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA

OPtimal Type 2 dIabetes Management Including Benchmarking and Standard Treatment in CEEMEA (OPTIMISE)

OPTIMISE-CEEMEA is a multinational, multi-centre, observational, prospective study which will include patients suffering from diabetes type 2, treated or untreated, insulin dependent or not insulin dependent.

In this study we aim to explore at a primary care level whether the use of benchmarking against a set of guideline-based reference values on a patient basis, may improve quality of patient care, in particular control of diabetes, lipids and blood pressure.

Inclusion Criteria:

• Subjects suffering from diabetes type 2,
• treated or untreated,
• insulin dependent or not insulin dependent Able to read and send SMS (if SMS applicable)

Exclusion Criteria:

• Type 1 diabetes Pregnancy diabetes
• Hospitalization at the moment of enrollment in the study